Search for: "MAXIM PHARMACEUTICALS, INC."
Results 81 - 100
of 147
Sorted by Relevance
|
Sort by Date
18 Apr 2012, 1:29 pm
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
18 Sep 2020, 7:49 am
Act Fast Delivery of West Virginia Inc., et al., No. 16-09788 (S.D.W.Va. [read post]
31 Oct 2012, 6:45 am
©2012 Amaxx Risk Solutions, Inc. [read post]
2 Jun 2014, 8:34 am
©2014 Amaxx Risk Solutions, Inc. [read post]
2 Jun 2014, 8:34 am
©2014 Amaxx Risk Solutions, Inc. [read post]
26 Dec 2007, 8:05 am
The explication of the plaintiffs' maximal position is very well presented. [read post]
20 Feb 2024, 4:56 pm
In Acqis Technology, Inc. v. [read post]
13 Jul 2021, 10:58 am
In turn, maximizing IP privileges for producers became, and has generally continued to be, a fixture of US international trade policy priorities.[8] II. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
18 May 2009, 5:24 am
: Omnicare, Inc v OHIM, Astellas Pharma GmbH (Class 46) CFI delivers judgment in case concerning ability of designer who assigns business and related IP to another company, to object when the company tries to register his name as a CTM: Elio Fiorucci v OHIM (IPKat) CFI: Good faith irrelevant when selling non-misleading sausages: Alberto Severi, in his own name and representing Cavazzuti e figli SpA, now known as Grandi Salumifici Italiani SpA v Regione Emilia-Romagna (IPKat) CFI clarifies… [read post]
6 Jan 2011, 12:43 pm
Make it a point to maximize your success by accomplishing the workers' compensation resolutions you make for the New Year Author Rebecca Shafer, JD, President of Amaxx Risks Solutions, Inc. is a national expert in the field of workers compensation. [read post]
19 May 2010, 4:27 pm
©2009 Amaxx Risk Solutions, Inc. [read post]
8 Jun 2011, 5:00 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
10 Mar 2012, 4:39 pm
©2012 Amaxx Risk Solutions, Inc. [read post]
5 Oct 2011, 5:07 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
20 Oct 2011, 5:48 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
29 Apr 2010, 4:50 am
© 2010 Amaxx Risk Solutions, Inc. [read post]
20 Jan 2011, 5:40 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
22 Aug 2007, 10:44 am
Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) (“Daubert”) concerning the admissibility of expert testimony and Federal Rules of Civil Procedure, Rule 56 for summary judgment. [read post]
23 Mar 2010, 2:00 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
